Buspirone Hydrochloride
Product Images NDC 53002-5017

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 53002-5017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B7db4c3d-72e4-420c-9b81-119646c13c85-01 (B7db4c3d 72e4 420c 9b81 119646c13c85 01)

Chemical structure diagram of BusPIRone Hydrochloride, showing its molecular connectivity and arrangement, as represented in the FDA SPL submission from RPK Pharmaceuticals, Inc.*

FDA Label Image

B7db4c3d-72e4-420c-9b81-119646c13c85-02 (B7db4c3d 72e4 420c 9b81 119646c13c85 02)

BusPIRone Hydrochloride white capsule-shaped pills with imprint "100" on one side and "555" on the other side. Product is associated with RPK Pharmaceuticals, Inc., NDC 53002-5017.*

FDA Label Image

B7db4c3d-72e4-420c-9b81-119646c13c85-03 (B7db4c3d 72e4 420c 9b81 119646c13c85 03)

The image shows a white, rectangular tablet scored into two halves. Each half is marked with the number '5' in black.*

FDA Label Image

B7db4c3d-72e4-420c-9b81-119646c13c85-04 (B7db4c3d 72e4 420c 9b81 119646c13c85 04)

The image shows a white, capsule-shaped pill with the imprint '5' on one side. This pill is likely part of BusPIRone Hydrochloride medication, distributed by RPK Pharmaceuticals, Inc.*

FDA Label Image

B7db4c3d-72e4-420c-9b81-119646c13c85-05 (B7db4c3d 72e4 420c 9b81 119646c13c85 05)

FDA Label Image

B7db4c3d-72e4-420c-9b81-119646c13c85-06 (B7db4c3d 72e4 420c 9b81 119646c13c85 06)

An instructional line drawing showing four fingers holding a scored tablet, demonstrate breaking the tablet at the scored line by applying pressure with the thumbs and index fingers.*

FDA Label Image

B7db4c3d-72e4-420c-9b81-119646c13c85-07 (B7db4c3d 72e4 420c 9b81 119646c13c85 07)

BusPIRone Hydrochloride capsules showing imprint codes '1 | 01' and '10 | 10 | 10' on two different capsule styles. The image depicts the imprint details used for identification of this medication from RPK Pharmaceuticals, Inc.*

FDA Label Image

B7db4c3d-72e4-420c-9b81-119646c13c85-08 (B7db4c3d 72e4 420c 9b81 119646c13c85 08)

BusPIRone Hydrochloride 10 mg tablet, scored with the number '10' printed on one side and a score dividing the tablet into two sections. The image shows a white tablet, allowing it to be divided for dosing.*

FDA Label Image

B7db4c3d-72e4-420c-9b81-119646c13c85-09 (B7db4c3d 72e4 420c 9b81 119646c13c85 09)

BusPIRone Hydrochloride tablet imprinted with '10 1' on one side, showing an oblong shape with a scored line. No other visible markings or text. Labeler: RPK Pharmaceuticals, Inc.*

FDA Label Image

B7db4c3d-72e4-420c-9b81-119646c13c85-10 (B7db4c3d 72e4 420c 9b81 119646c13c85 10)

BusPIRone Hydrochloride tablet scored and imprinted with "10" indicating a 10 mg strength, manufactured by RPK Pharmaceuticals, Inc.*

FDA Label Image

B7db4c3d-72e4-420c-9b81-119646c13c85-11 (B7db4c3d 72e4 420c 9b81 119646c13c85 11)

Illustration showing two hands pressing on a tablet to break it into two halves, demonstrating how to split a buspirone hydrochloride tablet.*

FDA Label Image

Label Image (Lbl530025017)

BusPIRone Hydrochloride 15 mg tablets packaging label from RPK Pharmaceuticals, Inc., containing 30 tablets. The label includes dosing instructions to take one tablet twice a day or as directed. It shows the NDC as 53002-5017 and notes the medication is an anti-anxiety agent. Additional details include lot number, expiration date, and space for patient and prescriber information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.